H1N1 Vaccines Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2018–2024

Request Brochure Request Discount

Report Code: ZMR-2976 | Report Format : | Status : Upcoming |

Abstract

H1N1 Vaccines Market: Overview

The H1N1 flu epidemic created a public health emergency in 2009. It also created an opportunity for vaccine manufacturers to exhibit that working with various initiatives, both private and government-held entities around the world, they could manufacture and distribute a vaccine for the virus strain which resulted in rapidly rising deaths worldwide.

H1N1 influenza virus vaccine is used to prevent infection caused by the H1N1 influenza virus.

H1N1 Vaccines Market: Market Dynamics

Some of the major anticipated drivers for this market include resurgence of H1N1 virus, emerging economies, irregular mutation of the virus which generates the need for continuous innovation of new vaccines, antigenic shifts of the virus leads to generation of new influenza virus types, innovation in vaccine manufacturing in order to obtain a universally acceptable vaccine for H1N1 virus, increased awareness on H1N1 influenza, Cost effective manufacturing of H1N1 vaccine, New funding opportunities by government, NGOs and donations, new research techniques and vaccine manufacturing technologies, new target population and improved profitability for the industry.

Unaffordable prices of the H1N1 vaccines by the lower and middle-class group, long period of time invested for discovering a new form of the vaccine, stringent regulatory rules, the absence of experienced medical professionals and high capital requirement are expected to restrain the growth of H1N1 vaccines market

Ample production to meet the population demand, developing vaccine much more effective than the current ones are few challenges forecasted in this market.

Segmentation based on the type of vaccine:

Based on vaccine type the market is categorized into intranasal, conjugate, attenuated vaccines, inactivated vaccine, intramuscular and toxoid.

Segmentation based on the disease type:

On the basis of disease type, the market is segmented by cervical cancer, influenza, mumps, measles, meningococcal, hepatitis, pneumococcal, rubella and other disease types.

Segmentation based on the brand type:

Depending on the type of brand devices, the market is segregated into agripal, nasovac, influvac, fiuarix, vaxigrip, influgen and other brands.

Segmentation based on regions:

North America and Europe dominate the global H1N1 vaccines market due to their improved research infrastructure and developing research techniques leading to the faster discovery of the disease prevention. The U.S. holds the largest market for H1N1 vaccines in North America, which is followed by Canada. Japan, China, and India are anticipated to be the fastest growing H1N1 vaccines market in Asia owing to the increasing awareness among people about preventable diseases, government launched programs to eradicate such infectious diseases and their causes, low wages to be paid to the workers, availability of a large talent pool and skilled personnel and less stringent environment and health safety regulations in these regions.

H1N1 Vaccines Market: Competitors

Abbott labs, CPL Biologicals Pvt. Ltd., bioCSL, GlaxoSmithKline Plc, MedImmune LLC, Novartis AG, Sanofi Pasteur AG, AstraZeneca, Baxter International, Mitsubishi Tanabe Pharma, Sinovac Biotech Ltd., Protein Sciences Corporation and Zydus Cadila are few of the key players in this market.

H1N1 Vaccines Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • The UK
    • France
    • Germany
  • The Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Related Reports

Pain Management Therapeutics Market by Drug Class (Anesthetics, NSAIDS, Anticonvulsants, Antidepressants, Anti-migraine agents, Non-narcotic Analgesics, and Opioids (Tramadol, Oxycodone, Hydrocodone, and Others)); by Indication (Neuropathic Pain, Arthritic Pain, Cancer Pain, Post-operative Pain, Chronic Back Pain, Fibromyalgia, and Migraine), and by Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, and Online Pharmacy): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Sep-2018 | Price : $ 4899.00 | Pages: 130 | Report Code: ZMR-3373 | Report Format:

The report covers forecast and analysis for the pain management therapeutics market on a global and regional level. The study provides historic data for 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the pa...Read More

Healthcare Regulatory Affairs Outsourcing Market by Services (Regulatory Writing and Publishing, Regulatory Submissions, Clinical Trial Applications and Services Registrations, Regulatory Consulting and Legal Representation, and Other Regulatory Affairs) and by End-User (Mid-Size Pharmaceutical Companies, Large Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, and Food and Beverage Companies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Sep-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3369 | Report Format:

The report covers forecast and analysis for the healthcare regulatory affairs outsourcing market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints fo...Read More

Thrombosis Drug Market by Drug Class (Factor Xa Inhibitor, Low Molecular Weight Heparin, and P2Y12 Platelet Inhibitor), by Indications (Pulmonary Embolism, Atrial Fibrillation, and Deep Vein Thrombosis), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017- 2024

Sep-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3363 | Report Format:

The report covers forecast and analysis for the thrombosis drug market on a global and regional level. The study provides historical data from 2015 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the thrombosis drug market along...Read More

Artificial Intelligence in Diabetes Management Market by Device (Glucose Monitoring Devices, Diagnostic Devices, Insulin Delivery Devices, and Other Devices) and by Technique Type (Case-based Reasoning and Intelligent Data Analysis): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 – 2024

Sep-2018 | Price : $ 4899.00 | Pages: 160 | Report Code: ZMR-3361 | Report Format:

The report covers forecast and analysis for the artificial intelligence in diabetes management market on a global and regional level. The study provides historical data from 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and ...Read More

Download Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.